Table 8.
Efficacy of prediction model in validation sample
| Patients | Prediction model 1 | Prediction model 2† | ||
|---|---|---|---|---|
|
|
|
|||
| Sensitivity (95% CI) | Specificity (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | |
| FAIP vs. PC (%) | 91.8 (0.864–0.973) | 95.6 (0.849–0.995) | 83.7 (0.764–0.910) | 93.3 (0.817–0.986) |
| FAIP with jaundice vs. PC with jaundice (%) | 87.5 (0.788–0.962) | 97.1 (0.851–0.999) | 78.6 (0.678–0.893) | 91.4 (0.769–0.982) |
| FAIP without jaundice vs. PC without jaundice (%) | 97.6 (0.874–0.999) | 90.0 (0.555–0.998) | 90.5 (0.774–0.973) | 100 (0.692–1.000) |
†Exclude the variables of diffuse/focal hypoechogenicity. FAIP: Focal autoimmune pancreatitis; PC: Pancreatic cancer, CI: Confidence interval